Ha Eun Kim

Ha Eun Kim

Auto-generated profile, based on publicly available information

Ha Eun Kim

Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2022 in Thoracic Cancer
Verified
Journal Article
Open access
YYYoung Ho Yang
Young Ho Yang
SPSeong Yong Park
Seong Yong Park
HKHa Eun Kim
Ha Eun Kim
BPByung Jo Park
Byung Jo Park
CLChang Young Lee
Chang Young Lee
HPHyo Chae Paik
Hyo Chae Paik
Background: The purpose of this study was to investigate the results of postoperative bronchopleural fistula repair and to identify adverse factors for its success.Methods: We retrospectively reviewed the surgical results of 39 patients who underwent surgical repair for postoperative bronchopleural fistula between January 2010 and June 2020. Success of bronchopleural fistula repair was defined as the visual closure of the bronchopleural fistula with the absence of an air leak, a recurrence of bronchopleural fistula and infection in the thoracic cavity.Results: Twenty‐five (64.1%) bronchopleural fistulas occurred after pulmonary resection and 14 (35.9%) after lung transplantation. Bronchopleural fistula was diagnosed 19 days (median) and repaired 28 days (median) after the initial operation by primary closure in 27 (69.2%) patients, and by additional resection in 12 (30.8%) patients. The overall success rate was 59% (23/39) and the overall mortality was 56.4% (22/39). Multivariable analysis revealed that the patients who were supported by mechanical ventilation at the time of repair had significantly lower success rates than those without (15.4%, 2/13 vs. 80.8%, 21/26, respectively, p < 0.001). The omental flap group tended to have a better success rate than the muscle flap group (p = 0.07).Conclusions: There was a high overall mortality rate after bronchopleural fistula repair and a low success rate. Mechanical ventilation at the time of bronchopleural fistula repair was significantly related to the failure of bronchopleural fistula repair.

7 November 2022 in Thoracic Cancer
Verified
Journal Article
Open access
Wongi WooWongi Woo
Wongi Woo
YYYoung Ho Yang
Young Ho Yang
Yoon Jin ChaYoon Jin Cha
Yoon Jin Cha
DMDuk Hwan Moon
Duk Hwan Moon
HSHyo Sup Shim
Hyo Sup Shim
CLChang Young Lee
Chang Young Lee
Background: The prognosis of invasive mucinous adenocarcinoma (IMA) remains controversial and should be clarified by comparison with the International Association for the Study of Lung Cancer (IASLC) histologic grading system for invasive nonmucinous adenocarcinoma (INMA).Methods: This study included patients with IMA who underwent curative resection. Their clinicopathological outcomes were compared with those of patients with INMA. Propensity score matching was performed to compare the prognosis of IMA with IASLC grade 2 or 3. Kaplan–Meier survival curves and log‐rank tests were used to analyze recurrence‐free survival (RFS) and overall survival (OS).Results: The prognoses of IMA and IASLC grade 2 were similar in terms of RFS and OS. Although patients with IMA had better RFS than patients with IASLC grade 3, the OS was not significantly different. After propensity score matching, IMA demonstrated similar RFS to IASLC grade 2 but superior to IASLC grade 3; there was no difference in the OS compared with grades 2/3. Multivariate analysis revealed that tumor size (hazard ratio [HR] = 1.20, p = 0.028), lymphovascular invasion (HR = 127.5, p = 0.003), and maximum standardized uptake value (HR = 1.24, p = 0.005) were poor prognostic predictors for RFS. Patients with IMA demonstrated RFS similar to and significantly better than that of patients with IASLC grades 2 and 3, respectively. For OS, IMA prognosis was between that of IASLC grades 2 and 3.Conclusions: Since the prognosis of IMA among lung adenocarcinomas appears to be relatively worse, further clinical studies investigating IMA‐specific treatment and follow‐up plans are necessary to draw more inferences.

1 May 2021 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
HKHa Eun Kim
Ha Eun Kim
SPSeong Yong Park
Seong Yong Park
HKHyunki Kim
Hyunki Kim
DKDae Joon Kim
Dae Joon Kim
SKSun Ill Kim
Sun Ill Kim
Background Although perineural invasion is a well known prognostic factor used in several cancers, its prognostic role in esophageal squamous cell carcinoma remains controversial. Here, we investigated the prognostic role of perineural invasion in surgically treated esophageal squamous cell carcinoma. Methods We retrospectively reviewed the medical records of 316 patients who underwent esophagectomy and lymph node dissection for esophageal squamous cell carcinoma between 2007 and 2016. Results Overall, 287 men (mean age: 62.73 +/- 7.97 years) were included in the study. The median follow-up period was 35.97 +/- 30.99 months, perineural invasion was confirmed in 25 patients, and three-year overall and disease-free survival were significantly lower in the perineural invasion group than in the no-perineural invasion group (75.9% vs. 40.0%, p < 0.001; 70.3% vs. 21.6%, p < 0.001). Cumulative incidences of locoregional recurrence and distant metastasis over three years were higher in the perineural invasion group (13.8% vs. 9.6%, p = 0.009 and 52.8% vs. 14.6%, p < 0.001). On performing multivariable analysis, perineural invasion, pathological stage, incomplete resection, and neoadjuvant therapy were adverse risk factors for disease-free survival. The concordance index increased when perineural invasion was included in the model (0.712 vs. 0.723). On subgroup analysis, perineural invasion demonstrated a prognostic value in node-negative patients (79.4% vs. 35.7%, p = 0.012). Conclusions Perineural invasion was found to be an adverse risk factor for disease-free survival in surgically treated patients with esophageal squamous cell carcinoma. Close observation and individualized adjuvant therapy may be helpful for patients with perineural invasion.

1 January 2021 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
HKHa Eun Kim
Ha Eun Kim
HPHyo Chae Paik
Hyo Chae Paik
SJSu Jin Jeong
Su Jin Jeong
MPMoo Suk Park
Moo Suk Park
SKSong Yee Kim
Song Yee Kim
JLJin Gu Lee
Jin Gu Lee
Kim HE, et al. Yonsei Med J. 2021 Feb;62(2):164-171. https://doi.org/10.3349/ymj.2021.62.2.164

14 December 2021 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
HKHa Eun Kim
Ha Eun Kim
WYWoo Sik Yu
Woo Sik Yu
CLChang Young Lee
Chang Young Lee
JLJin Gu Lee
Jin Gu Lee
DKDae Joon Kim
Dae Joon Kim
SPSeong Yong Park
Seong Yong Park
Background: We aimed to investigate the characteristics and pretreatment risk factors for postoperative pulmonary complications (PPCs) after neoadjuvant concurrent chemoradiotherapy (CRTx) in patients with non‐small cell lung cancer (NSCLC).Methods: We retrospectively reviewed data of 122 patients who underwent curative resection after neoadjuvant CRTx for NSCLC between 2007 and December 2019. Clinical data, including pulmonary function and body mass index (BMI) at the time of concurrent CRTx initiation, were analyzed. We performed logistic regression analyses to identify the risk factors for PPCs and built a nomogram with significant factors.Results: Of the 122 patients included (mean age, 60.1 ± 9.7 years; 69.7% male), 27 experienced PPCs (severity grade ≥ 2). The most common PPCs were pneumonia (n = 17). Patients with PPCs had a significantly longer hospital stay (median 6.0 vs. 17 days, p < 0.001) and a higher in‐hospital mortality rate (1.1% vs. 29.6%, p < 0.001). In multivariable analysis, lower BMI (odds ratio [OR] 0.796, 95% confidence interval [CI] 0.628–0.987, p = 0.038), no comorbidity (OR 0.220, 95% CI: 0.059–0.819, p = 0.048), smoking history (OR 4.362, 95% CI: 1.210–15.720, p = 0.024), and %predicted DLCO <60% (OR 3.727, 95% CI: 1.319–10.530, p = 0.013) were independent risk factors for PPCs. The predictive accuracy of the nomogram built with factors was excellent (concordance index: 0.756).Conclusions: The nomogram constructed with factors identified in multivariable analysis could serve as a reliable tool for evaluating the risk of PPCs in the patients who underwent neoadjuvant CRTx for NSCLC.

5 December 2018 in The Korean Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
HKHa Eun Kim
Ha Eun Kim
HPHyo Chae Paik
Hyo Chae Paik
SKSong Yee Kim
Song Yee Kim
MPMoo Suk Park
Moo Suk Park
JLJin Gu Lee
Jin Gu Lee
Ha Eun Kim, M.D., Hyo Chae Paik, M.D., Song Yee Kim, M.D., Moo Suk Park, M.D., and Jin Gu Lee, M.D.. Korean J Thorac Cardiovasc Surg 2018;51:384-9. https://doi.org/10.5090/kjtcs.2018.51.6.384